Learn more about the use of GLP-1 agonists to improve weight loss in transplant candidates and candidacy for living donors, as well as the management and safety of GLP-1 agonists once patients undergo transplant/donation.
Why is this topic important?
GLP-1 agonists are being used widely for weight loss, but establishing safety and efficacy in transplant is yet to be determined. It is important to understand the current practice/attitudes of transplant programs towards GLP-1 agonists and use in potential recipients and potential living donors. Establishing safe and acceptable practices in transplant to obtain and maintain goal weight during various phases of care will help improve transplant patient outcomes.
Speakers:
Moderator:
Objectives:
The AST Education Committee would like to thank AST's TxPharm COP, LDCOP, KPCOP, and PSECOP for suggesting this topic for the 2024-2025 T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
More about Timely Topics in Transplantation (T3) webinars: